Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease

By M. Corsten, R. Dennert, Sylvia H. J. Jochems, T. Kuznetsova, Y. Devaux, L. Hofstra, D. Wagner, J. Staessen, S. Heymans, B. Schroen. Circulation: Cardiovascular Genetics, 2010

810 citations recorded by the source corpus.

Subfields: Cancer Research, Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/76a4048ba23e16544e24b4d3f254da1831ec89cd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Jin Wang
2. S. Sen
3. Jinyun Chen

Citations in the corpus

• miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis (2020, result): “have pointed out that this elevation was rather more moderate compared to the ones detected in the case of miR-208b and miR-499 [59].”
• Comparing the MicroRNA Spectrum between Serum and Plasma (2012, background): “For example, the liver-specific miR-122 in druginduced liver injury [12,13], the muscle-specific miR-133a and b in muscle injury [13] and heart-specific miR-208 and miR-499 in myocardial infarction [5,14].”
• microRNA as Biomarkers and Diagnostics (2016, background): “They are quantitatively altered in certain disease entities, such as myocardial infarction, atherosclerosis, coronary artery disease, heart failure, atrial fibrillation, hypertrophy, and fibrosis (Corsten et al., 2010; Fichtlscherer et al., 2010; da Silva and Silbiger, 2014).”